Global Non-Invasive Prenatal Testing (NIPT) Market to Reach $9.2 Billion by 2030

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

 | Source: ReportLinker ReportLinker

New York, May 17, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Non-Invasive Prenatal Testing (NIPT) Industry" - https://www.reportlinker.com/p06032345/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Non-Invasive Prenatal Testing (NIPT) Market to Reach $9.2 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Non-Invasive Prenatal Testing (NIPT) estimated at US$2.9 Billion in the year 2022, is projected to reach a revised size of US$9.2 Billion by 2030, growing at aCAGR of 15.3% over the period 2022-2030. Consumables & Reagents, one of the segments analyzed in the report, is projected to record 12.4% CAGR and reach US$5.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 21.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $799.5 Million, While China is Forecast to Grow at 19.5% CAGR

The Non-Invasive Prenatal Testing (NIPT) market in the U.S. is estimated at US$799.5 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 19.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.6% and 13.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 12.1% CAGR.

Select Competitors (Total 33 Featured)
- Agilent Technologies, Inc.
- Berry Genetics Inc.
- BGI Genomics Co. Ltd.
- Eurofins LifeCodexx GmbH
- F. Hoffmann-La Roche Ltd.
- GE Healthcare
- Igenomix
- Illumina, Inc.
- Laboratory Corporation of America Holdings
- Natera, Inc.
- PerkinElmer Inc.
- Thermo Fisher Scientific Inc.
- Yourgene Health


Read the full report: https://www.reportlinker.com/p06032345/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Non-Invasive Prenatal Testing (NIPT) - Global Key Competitors
Percentage Market Share in 2021 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2021 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Ultrasound Detection by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 2: World Historic Review for Ultrasound Detection by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 3: World 16-Year Perspective for Ultrasound Detection by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for
Biochemical Screening Tests by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR

Table 5: World Historic Review for Biochemical Screening Tests
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 6: World 16-Year Perspective for Biochemical Screening
Tests by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2014, 2023 &
2030

Table 7: World Recent Past, Current & Future Analysis for
Cell-free DNA in Maternal Plasma Tests by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2022 through 2030 and % CAGR

Table 8: World Historic Review for Cell-free DNA in Maternal
Plasma Tests by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 9: World 16-Year Perspective for Cell-free DNA in
Maternal Plasma Tests by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2014, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Trisomy by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 11: World Historic Review for Trisomy by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 12: World 16-Year Perspective for Trisomy by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Microdeletion Syndrome by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR

Table 14: World Historic Review for Microdeletion Syndrome by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 15: World 16-Year Perspective for Microdeletion Syndrome
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 17: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 18: World 16-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for
Diagnostic Laboratories by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR

Table 20: World Historic Review for Diagnostic Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 21: World 16-Year Perspective for Diagnostic Laboratories
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 22: World Recent Past, Current & Future Analysis for
Hospitals by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 23: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 24: World 16-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 25: World Non-Invasive Prenatal Testing (NIPT) Market
Analysis of Annual Sales in US$ Million for Years 2014 through
2030

Table 26: World Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2022 through 2030 and % CAGR

Table 27: World Historic Review for Non-Invasive Prenatal
Testing (NIPT) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 28: World 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2014, 2023 & 2030

Table 29: World Recent Past, Current & Future Analysis for
Consumables & Reagents by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR

Table 30: World Historic Review for Consumables & Reagents by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 31: World 16-Year Perspective for Consumables & Reagents
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 32: World Recent Past, Current & Future Analysis for
Instruments by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 33: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 34: World 16-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

UNITED STATES
Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United States
for 2023 (E)
Table 35: USA Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA
in Maternal Plasma Tests, Ultrasound Detection and Biochemical
Screening Tests - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 36: USA Historic Review for Non-Invasive Prenatal Testing
(NIPT) by Method - Cell-free DNA in Maternal Plasma Tests,
Ultrasound Detection and Biochemical Screening Tests Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 37: USA 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by Method - Percentage Breakdown of Value Sales
for Cell-free DNA in Maternal Plasma Tests, Ultrasound
Detection and Biochemical Screening Tests for the Years 2014,
2023 & 2030

Table 38: USA Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy,
Microdeletion Syndrome and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 39: USA Historic Review for Non-Invasive Prenatal Testing
(NIPT) by Application - Trisomy, Microdeletion Syndrome and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 40: USA 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by Application - Percentage Breakdown of Value
Sales for Trisomy, Microdeletion Syndrome and Other
Applications for the Years 2014, 2023 & 2030

Table 41: USA Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and
Diagnostic Laboratories - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 42: USA Historic Review for Non-Invasive Prenatal Testing
(NIPT) by End-Use - Hospitals and Diagnostic Laboratories
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 43: USA 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales
for Hospitals and Diagnostic Laboratories for the Years 2014,
2023 & 2030

Table 44: USA Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by Product - Consumables &
Reagents and Instruments - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 45: USA Historic Review for Non-Invasive Prenatal Testing
(NIPT) by Product - Consumables & Reagents and Instruments
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 46: USA 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by Product - Percentage Breakdown of Value Sales
for Consumables & Reagents and Instruments for the Years 2014,
2023 & 2030

CANADA
Table 47: Canada Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA
in Maternal Plasma Tests, Ultrasound Detection and Biochemical
Screening Tests - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 48: Canada Historic Review for Non-Invasive Prenatal
Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma
Tests, Ultrasound Detection and Biochemical Screening Tests
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 49: Canada 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by Method - Percentage Breakdown of Value Sales
for Cell-free DNA in Maternal Plasma Tests, Ultrasound
Detection and Biochemical Screening Tests for the Years 2014,
2023 & 2030

Table 50: Canada Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy,
Microdeletion Syndrome and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 51: Canada Historic Review for Non-Invasive Prenatal
Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 52: Canada 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by Application - Percentage Breakdown of Value
Sales for Trisomy, Microdeletion Syndrome and Other
Applications for the Years 2014, 2023 & 2030

Table 53: Canada Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and
Diagnostic Laboratories - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 54: Canada Historic Review for Non-Invasive Prenatal
Testing (NIPT) by End-Use - Hospitals and Diagnostic
Laboratories Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 55: Canada 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales
for Hospitals and Diagnostic Laboratories for the Years 2014,
2023 & 2030

Table 56: Canada Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by Product - Consumables &
Reagents and Instruments - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 57: Canada Historic Review for Non-Invasive Prenatal
Testing (NIPT) by Product - Consumables & Reagents and
Instruments Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 58: Canada 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by Product - Percentage Breakdown of Value Sales
for Consumables & Reagents and Instruments for the Years 2014,
2023 & 2030

JAPAN
Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
Table 59: Japan Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA
in Maternal Plasma Tests, Ultrasound Detection and Biochemical
Screening Tests - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 60: Japan Historic Review for Non-Invasive Prenatal
Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma
Tests, Ultrasound Detection and Biochemical Screening Tests
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 61: Japan 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by Method - Percentage Breakdown of Value Sales
for Cell-free DNA in Maternal Plasma Tests, Ultrasound
Detection and Biochemical Screening Tests for the Years 2014,
2023 & 2030

Table 62: Japan Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy,
Microdeletion Syndrome and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 63: Japan Historic Review for Non-Invasive Prenatal
Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 64: Japan 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by Application - Percentage Breakdown of Value
Sales for Trisomy, Microdeletion Syndrome and Other
Applications for the Years 2014, 2023 & 2030

Table 65: Japan Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and
Diagnostic Laboratories - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 66: Japan Historic Review for Non-Invasive Prenatal
Testing (NIPT) by End-Use - Hospitals and Diagnostic
Laboratories Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 67: Japan 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales
for Hospitals and Diagnostic Laboratories for the Years 2014,
2023 & 2030

Table 68: Japan Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by Product - Consumables &
Reagents and Instruments - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 69: Japan Historic Review for Non-Invasive Prenatal
Testing (NIPT) by Product - Consumables & Reagents and
Instruments Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 70: Japan 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by Product - Percentage Breakdown of Value Sales
for Consumables & Reagents and Instruments for the Years 2014,
2023 & 2030

CHINA
Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in China for 2023 (E)
Table 71: China Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA
in Maternal Plasma Tests, Ultrasound Detection and Biochemical
Screening Tests - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 72: China Historic Review for Non-Invasive Prenatal
Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma
Tests, Ultrasound Detection and Biochemical Screening Tests
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 73: China 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by Method - Percentage Breakdown of Value Sales
for Cell-free DNA in Maternal Plasma Tests, Ultrasound
Detection and Biochemical Screening Tests for the Years 2014,
2023 & 2030

Table 74: China Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy,
Microdeletion Syndrome and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 75: China Historic Review for Non-Invasive Prenatal
Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 76: China 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by Application - Percentage Breakdown of Value
Sales for Trisomy, Microdeletion Syndrome and Other
Applications for the Years 2014, 2023 & 2030

Table 77: China Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and
Diagnostic Laboratories - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 78: China Historic Review for Non-Invasive Prenatal
Testing (NIPT) by End-Use - Hospitals and Diagnostic
Laboratories Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 79: China 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales
for Hospitals and Diagnostic Laboratories for the Years 2014,
2023 & 2030

Table 80: China Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by Product - Consumables &
Reagents and Instruments - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 81: China Historic Review for Non-Invasive Prenatal
Testing (NIPT) by Product - Consumables & Reagents and
Instruments Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 82: China 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by Product - Percentage Breakdown of Value Sales
for Consumables & Reagents and Instruments for the Years 2014,
2023 & 2030

EUROPE
Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
Table 83: Europe Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA
in Maternal Plasma Tests, Ultrasound Detection and Biochemical
Screening Tests - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 84: Europe Historic Review for Non-Invasive Prenatal
Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma
Tests, Ultrasound Detection and Biochemical Screening Tests
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 85: Europe 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by Method - Percentage Breakdown of Value Sales
for Cell-free DNA in Maternal Plasma Tests, Ultrasound
Detection and Biochemical Screening Tests for the Years 2014,
2023 & 2030

Table 86: Europe Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy,
Microdeletion Syndrome and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 87: Europe Historic Review for Non-Invasive Prenatal
Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 88: Europe 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by Application - Percentage Breakdown of Value
Sales for Trisomy, Microdeletion Syndrome and Other
Applications for the Years 2014, 2023 & 2030

Table 89: Europe Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and
Diagnostic Laboratories - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 90: Europe Historic Review for Non-Invasive Prenatal
Testing (NIPT) by End-Use - Hospitals and Diagnostic
Laboratories Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 91: Europe 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales
for Hospitals and Diagnostic Laboratories for the Years 2014,
2023 & 2030

Table 92: Europe Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by Geographic Region -
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 93: Europe Historic Review for Non-Invasive Prenatal
Testing (NIPT) by Geographic Region - France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 94: Europe 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia and
Rest of Europe Markets for Years 2014, 2023 & 2030

Table 95: Europe Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by Product - Consumables &
Reagents and Instruments - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 96: Europe Historic Review for Non-Invasive Prenatal
Testing (NIPT) by Product - Consumables & Reagents and
Instruments Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 97: Europe 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by Product - Percentage Breakdown of Value Sales
for Consumables & Reagents and Instruments for the Years 2014,
2023 & 2030

FRANCE
Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in France for 2023 (E)
Table 98: France Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA
in Maternal Plasma Tests, Ultrasound Detection and Biochemical
Screening Tests - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 99: France Historic Review for Non-Invasive Prenatal
Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma
Tests, Ultrasound Detection and Biochemical Screening Tests
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 100: France 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by Method - Percentage Breakdown of Value Sales
for Cell-free DNA in Maternal Plasma Tests, Ultrasound
Detection and Biochemical Screening Tests for the Years 2014,
2023 & 2030

Table 101: France Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy,
Microdeletion Syndrome and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 102: France Historic Review for Non-Invasive Prenatal
Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 103: France 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by Application - Percentage Breakdown of Value
Sales for Trisomy, Microdeletion Syndrome and Other
Applications for the Years 2014, 2023 & 2030

Table 104: France Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and
Diagnostic Laboratories - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 105: France Historic Review for Non-Invasive Prenatal
Testing (NIPT) by End-Use - Hospitals and Diagnostic
Laboratories Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 106: France 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales
for Hospitals and Diagnostic Laboratories for the Years 2014,
2023 & 2030

Table 107: France Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by Product - Consumables &
Reagents and Instruments - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 108: France Historic Review for Non-Invasive Prenatal
Testing (NIPT) by Product - Consumables & Reagents and
Instruments Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 109: France 16-Year Perspective for Non-Invasive Prenatal
Testing (NIPT) by Product - Percentage Breakdown of Value Sales
for Consumables & Reagents and Instruments for the Years 2014,
2023 & 2030

GERMANY
Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
Table 110: Germany Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA
in Maternal Plasma Tests, Ultrasound Detection and Biochemical
Screening Tests - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 111: Germany Historic Review for Non-Invasive Prenatal
Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma
Tests, Ultrasound Detection and Biochemical Screening Tests
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 112: Germany 16-Year Perspective for Non-Invasive
Prenatal Testing (NIPT) by Method - Percentage Breakdown of
Value Sales for Cell-free DNA in Maternal Plasma Tests,
Ultrasound Detection and Biochemical Screening Tests for the
Years 2014, 2023 & 2030

Table 113: Germany Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy,
Microdeletion Syndrome and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 114: Germany Historic Review for Non-Invasive Prenatal
Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 115: Germany 16-Year Perspective for Non-Invasive
Prenatal Testing (NIPT) by Application - Percentage Breakdown
of Value Sales for Trisomy, Microdeletion Syndrome and Other
Applications for the Years 2014, 2023 & 2030

Table 116: Germany Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and
Diagnostic Laboratories - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 117: Germany Historic Review for Non-Invasive Prenatal
Testing (NIPT) by End-Use - Hospitals and Diagnostic
Laboratories Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 118: Germany 16-Year Perspective for Non-Invasive
Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of
Value Sales for Hospitals and Diagnostic Laboratories for the
Years 2014, 2023 & 2030

Table 119: Germany Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by Product - Consumables &
Reagents and Instruments - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 120: Germany Historic Review for Non-Invasive Prenatal
Testing (NIPT) by Product - Consumables & Reagents and
Instruments Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 121: Germany 16-Year Perspective for Non-Invasive
Prenatal Testing (NIPT) by Product - Percentage Breakdown of
Value Sales for Consumables & Reagents and Instruments for the
Years 2014, 2023 & 2030

ITALY
Table 122: Italy Recent Past, Current & Future Analysis for
Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032345/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

 

            











    

        

        
Contact Data

        


    
    

 
    



        

        
            GlobeNewswire